Source comparison
BPC-157 Research Skin Considerations: Application Comparison
Intradermal 1–2mm (papillary dermis) 10–15° bevel up 0.1–0.3mL 24–48 hours Minimal (<5%) Wound healing models, localized angiogenesis studies Subcutaneous 4–10mm (hypodermis) 45–90° 0.5–1.0mL 48–96 hours Moderate (15–30%) Time-course protocols, sustained relea
This comparison does not assign a generated winner or score.
- Intradermal
- 1–2mm (papillary dermis)
- 10–15° bevel up
- 0.1–0.3mL
- 24–48 hours
- Minimal (<5%)
- Wound healing models, localized angiogenesis studies
- Subcutaneous
- 4–10mm (hypodermis)
- 45–90°
- 0.5–1.0mL
- 48–96 hours
- Moderate (15–30%)
- Time-course protocols, sustained release applications
- Topical (wound bed)
- Surface application
- N/A
- Variable (gel/solution)
- 12–24 hours
- None (0%)
- Open wound models, epithelialization measurement
- Professional Assessment
- Subcutaneous administration at 250–500 mcg/mL in 0.5mL volumes provides the optimal balance of localized tissue effect, measurement consistency, and minimal injection artifact for most dermal research protocols